Solving Erectile Dysfunction
The goal of this course is to explain how nurses can monitor and teach patients to safely use medications that selectively inhibit cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), first-line treatment for erectile dysfunction.

Course Publication Date: May 19, 2020

This course is available with NO ADDITIONAL FEE if you have an active one year unlimited membership!

Author:Denise L. Gray RN, MAS, BSN, CCM
Course No:SED010620
Contact Hours:1.00
Delivery Method:Online Self Study
Category:Community & Home Health
Emergency & Trauma Medicine
Geriatric Medicine
Medical & Surgical Issues
Psychiatric & Mental Health
  
Learning Objectives
  • Recognize examples of medications that selectively inhibit cGMP-specific phosphodiesterase type 5 (PDE5).

  • Identify possible drug interactions with cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.

  • Describe how nurses can monitor patients for possible adverse drug events resulting from cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.

  • Select information to teach patients taking cGMP-specific phosphodiesterase type 5 (PDE5) inhibitors.



 (234ms)
A4S-WEB1 18.207.160.97 url(WWW.MYFREECE.COM)-domain(WWW.MYFREECE.COM)-anon

Search Courses

Group Plan

Group plans are convenient and cost effective!

Authors Wanted


Earn $$$ as a MyFreeCE Author!